PER 1.27% 8.0¢ percheron therapeutics limited

Ann: Positive feedback received on Paediatric Investigation Plan, page-48

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 13,737 Posts.
    lightbulb Created with Sketch. 1461
    Let’s not lose heart because of the stagnant sp…

    https://www.ihealthcareanalyst.com/global-idiopathic-pulmonary-fibrosis-treatment-market/

    The market for fibrosis is $8 billion by 2027…
    Thats larger than the DMD market..

    So just on DMD and fibrosis Anp has a market of $13 billion… with no competition…

    In 16 months Anp could be earning $1 billion per annum..

    At the moment we have aMC of $127 million

    its a joke….

 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.001(1.27%)
Mkt cap ! $82.94M
Open High Low Value Volume
8.0¢ 8.3¢ 7.9¢ $461.5K 5.711M

Buyers (Bids)

No. Vol. Price($)
6 844186 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 292500 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.